 | Up a level |
Journal Article
Deckert, M., Engert, A., Brueck, W., Ferreri, A. J. M., Finke, J., Illerhaus, G., Klapper, W., Korfel, A., Kueppers, R., Maarouf, M., Montesinos-Rongen, M., Paulus, W., Schlegel, U., Lassmann, H., Wiestler, O. D., Siebert, R. and DeAngelis, L. M. (2011). Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia, 25 (12). S. 1797 - 1808. LONDON: NATURE PUBLISHING GROUP. ISSN 0887-6924
Lang, N., Esser, W., Evers, S., Kellinghaus, C., Nguento, A., Schlegel, U., Gaida, B., Gburek-Augustat, J., Altenmueller, D. M., Burghaus, L., Hoffmann, F., Fiedler, B., Bast, T., Rehfeld, T., Happe, S., Seitz, R. J., Boor, R. and Stephani, U. (2015). Intravenous levetiracetam in clinical practice - Results from an independent registry. Seizure, 29. S. 109 - 114. LONDON: W B SAUNDERS CO LTD. ISSN 1532-2688
Linnebank, M., Moskau, S., Kowoll, A., Semmler, A., Bangard, C., Vogt-Schaden, M., Egerer, G., Schackert, G., Reichmann, H., Schmidt-Wolf, I. G. H., Pels, H. and Schlegel, U. (2012). Association of transcobalamin c. 776C > G with overall survival in patients with primary central nervous system lymphoma. Br. J. Cancer, 107 (11). S. 1840 - 1844. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827